BioAegis Therapeutics Revenue

Biotechnology Research • North Brunswick, New Jersey, United States • 11-20 Employees

BioAegis Therapeutics revenue & valuation

Annual revenue	$608,000
Revenue per employee	$44,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$22,000,000

Key Contact at BioAegis Therapeutics

Steven Cordovano

Co-Founder

Company overview

Headquarters	675 US Route 1, North Brunswick, New Jersey 08902, US
Phone number	+19735394552
Websites	bioaegistherapeutics.com bioaegistx.com
NAICS	541714
SIC	873
Founded	2011
Employees	11-20
Socials

BioAegis Therapeutics Email Formats

BioAegis Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@bioaegistherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@bioaegistherapeutics.com	100%

About BioAegis Therapeutics

Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Founder/Owner

Employees by Department

BioAegis Therapeutics has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore BioAegis Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-04-22	1	$22,000,000

Funding Insights

$22,000,000

Total funding amount

$22,000,000

Most recent funding amount

Number of funding rounds

BioAegis Therapeutics Tech Stack

Discover the technologies and tools that power BioAegis Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

WP Fastest Cache

Performance

Astra

WordPress themes

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

MonsterInsights

Analytics

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Frequently asked questions

BioAegis Therapeutics is located in North Brunswick, New Jersey, US.

You can reach BioAegis Therapeutics at +19735394552.

BioAegis Therapeutics generates an estimated annual revenue of $608,000. This revenue figure reflects the company's market position and business performance in its industry.

BioAegis Therapeutics has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

BioAegis Therapeutics was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

BioAegis Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

BioAegis Therapeutics has raised a total of $22,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at BioAegis Therapeutics

Steven Cordovano

Co-Founder

4.8

40,000 users